Gyon Technologies Capital Management, LP Celldex Therapeutics, Inc. Transaction History

Gyon Technologies Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$27.78 - $45.38 $163,374 - $266,879	5,881 Added 53.69%	16,834 $750,000
Q3 2022 Nov 14, 2022	SELL	$22.7 - $37.57 $67,305 - $111,395	-2,965 Reduced 21.3%	10,953 $308,000
Q2 2022 Aug 15, 2022	BUY	$20.5 - $37.33 $69,003 - $125,652	3,366 Added 31.9%	13,918 $375,000
Q1 2022 May 12, 2022	SELL	$27.64 - $39.32 $216,587 - $308,111	-7,836 Reduced 42.61%	10,552 $359,000
Q4 2021 Feb 11, 2022	SELL	$35.68 - $56.27 $619,975 - $977,747	-17,376 Reduced 48.59%	18,388 $711,000
Q3 2021 Nov 18, 2021	BUY	$28.95 - $55.99 $1.04 Million - $2 Million	35,764 New	35,764 $1.93 Million

207

67.3M

1.69M

980K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.22B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.